COMP <GO>
RDY vs JAZZ // ENTERPRISE SCALE & MARKET CAP
Dr. Reddy's Laboratories Ltd (NYSE) VS. Jazz Pharmaceuticals plc (Ireland) (NASDAQ) • 15-METRIC TALLY: RDY 8
— JAZZ 3
▲ ENTERPRISE SCALE & MARKET CAP LEADER: JAZZ
LAST: $14.13 (-0.28%) • MKT CAP: $11.83B
market-cap
$11.83B
LAST: $214.44 (-0.71%) • MKT CAP: $14.02B
market-cap
$14.02B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RDY VS. JAZZ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | RDY | JAZZ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.90% | -4.70% | +14.60 | RDY | /roic <GO> |
| EV/EBITDA & P/E Valuation | 21.0x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 2.21% | 9.61% | -7.40 | JAZZ | /fcf-yield <GO> |
| Operating Margin | 13.90% | -10.10% | +24.00 | RDY | /operating-margins <GO> |
| Net Profit Margin | 10.90% | -8.30% | +19.20 | RDY | /net-margins <GO> |
| Revenue Growth (YoY) | 6.60% | 4.90% | +1.70 | RDY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.74 | 1.97 | +1.77 | RDY | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | RDY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 76.2 | 48.5 | +27.70 | RDY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.05 | 1.09 | -0.04 | JAZZ | /macro-sensitivity <GO> |
| Forward P/E Multiple | 30.5x | 36.0x | -5.50 | RDY | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $11.83B | $14.02B | -$2.19B | JAZZ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | RDY REV | JAZZ REV | RDY GROSS % | JAZZ GROSS % | RDY FCF | JAZZ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | — | $4.27B | — | — | — | $1.30B |
| FY 2024 | — | $4.07B | — | — | — | $1.36B |
| FY 2023 | — | $3.83B | — | — | — | $919.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RDY // BETA 1.05
JAZZ // BETA 1.09